According to Reuters, JPMorgan (JPM) cuts its dividend.

Reuters reports that AIG (AIG) got bids from Met Life and Axa for its life unit.

Reuters says that healthcare spending is taking a higher percentage of American spending.

Reuters reports that Yahoo! (YHOO) will offer tools that match users to ads.

Reuters reports that UBS (UBS) could face a trial over releasing its client’s names.

Reuters reports that the president of News Corp (NWS) is leaving.

The Wall Street Journal reports that the Dow is down 50% from its peak.

The Wall Street Journal reports that the new CEO of Toyota (TM) is driving the company back to its basics.

The Wall Street Journal reports that the new deal between Ford (F) and the UAW puts pressure on the other two US car companies.

The Wall Street Journal writes that AIG (AIG) is seeking better bailout terms from the government.

The Wall Street Journal reports that Lehman will spin off its venture capital arm.

The Wall Street Journal writes that Motorola (MOT) will sell its email unit.

The Wall Street Journal reports that Campbell was hurt as stores cut stocks.

The Wall Street Journal reports that the insurance premiums for officers and directors at banks is rising.

The Wall Street Journal writes that Micron will cut 2,000 jobs.

The Wall Street Journal reports that consumer confidence is likely to fall further.

The Wall Street Journal reports that hedge funds will advance a proposal to make their activities more transparent.

The Wall Street Journal writes that companies may be dropping the “poison pills:.

The Wall Street Journal reports that credit markets may take another turn for the worse.

The Wall Street Journal reports that Genentech (DNA) is pushing its investors to reject and offer by Roche.

The Wall Street Journal reports that Xerox (XRX) is expanding beyond copiers.

The Wall Street Journal reports that the net income and margins at Nordstrom (JWN) fell.

The Wall Street Journal reports that the FT is cutting personnel costs.

The New York Times reports that the US is being pressed by many industries to increase funds for the bailout.

The New York Times reports that trouble in economies in Eastern Europe are raising the cost of doing business there.

The New York Times reports that Medtronic’s (MDT) Sprint Fidelis lead is still causing problems for patients.

The FT reports that the tide has turned against huge buyout funds as they are blamed for over leveraged investments.

Bloomberg reports that plans to help Citigroup (C) may depend on it loans to hedge funds.

Douglas A. McIntyre

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.